Clinical Trial Update: AVODART® Alopecia Post-marketing Surveillance (PMS)

View source ↗

Summary

A post-marketing surveillance study evaluating dutasteride (Avodart) for alopecia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• Avodart (dutasteride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Alopecia | Status: COMPLETED